Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells

Yi Mi Wu, Dan R. Robinson, Hsing Jien Kung

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The AXL/UFO family of tyrosine kinases is characterized by a common N-CAM (neural adhesion molecule)-related extracellular domain and a common ligand, GAS6 (growth arrest-specific protein 6). Family members are prone to transcriptional regulation and carry out diverse functions including the regulation of cell adhesion, migration, phagocytosis, and survival. In this report, we describe a new role of MER/N-CAM-related kinase (NYK), a member of the AXL family of kinases, in the up-regulation of chemokines in prostate cancer cells. We show that NYK has elevated expression in a subset of tumor specimens and prostate cancer cell lines. Activation of NYK in the prostate cancer cell line DU145 does not cause a mitogenic effect; instead, it causes a differentiation phenotype. Microarray analysis revealed that NYK is a strong inducer of endocrine factors including interleukin (IL)-8 and several other angiogenic CXC chemokines as well as bone morphogenic factors. The dramatic increase of IL-8 expression is seen at both transcriptional and posttranscriptional levels. The downstream signals engaged by NYK were characterized, and those responsible for the up-regulation of IL-8 transcription were defined. In contrast to IL-1α, NYK-induced up-regulation of IL-8 in DU145 depends on the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase/Jun/Fos pathway, but not phosphoinositide 3′-kinase/ nuclear factor-κB. These data define a new function of the AXL family of kinases and suggest a potential role of NYK in prostate cancer progression.

Original languageEnglish
Pages (from-to)7311-7320
Number of pages10
JournalCancer Research
Volume64
Issue number20
DOIs
Publication statusPublished - Oct 15 2004
Externally publishedYes

Fingerprint

Interleukin-8
Chemokines
Protein-Tyrosine Kinases
Signal Transduction
Prostatic Neoplasms
Up-Regulation
Phosphotransferases
CXC Chemokines
Cell Line
1-Phosphatidylinositol 4-Kinase
Mitogen-Activated Protein Kinase Kinases
Extracellular Signal-Regulated MAP Kinases
Microarray Analysis
Interleukin-1
Phagocytosis
Cell Adhesion
Cell Movement
Ligands
Phenotype
Bone and Bones

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells. / Wu, Yi Mi; Robinson, Dan R.; Kung, Hsing Jien.

In: Cancer Research, Vol. 64, No. 20, 15.10.2004, p. 7311-7320.

Research output: Contribution to journalArticle

@article{d4bc8205cfae47d1bfc200200ba91781,
title = "Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells",
abstract = "The AXL/UFO family of tyrosine kinases is characterized by a common N-CAM (neural adhesion molecule)-related extracellular domain and a common ligand, GAS6 (growth arrest-specific protein 6). Family members are prone to transcriptional regulation and carry out diverse functions including the regulation of cell adhesion, migration, phagocytosis, and survival. In this report, we describe a new role of MER/N-CAM-related kinase (NYK), a member of the AXL family of kinases, in the up-regulation of chemokines in prostate cancer cells. We show that NYK has elevated expression in a subset of tumor specimens and prostate cancer cell lines. Activation of NYK in the prostate cancer cell line DU145 does not cause a mitogenic effect; instead, it causes a differentiation phenotype. Microarray analysis revealed that NYK is a strong inducer of endocrine factors including interleukin (IL)-8 and several other angiogenic CXC chemokines as well as bone morphogenic factors. The dramatic increase of IL-8 expression is seen at both transcriptional and posttranscriptional levels. The downstream signals engaged by NYK were characterized, and those responsible for the up-regulation of IL-8 transcription were defined. In contrast to IL-1α, NYK-induced up-regulation of IL-8 in DU145 depends on the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase/Jun/Fos pathway, but not phosphoinositide 3′-kinase/ nuclear factor-κB. These data define a new function of the AXL family of kinases and suggest a potential role of NYK in prostate cancer progression.",
author = "Wu, {Yi Mi} and Robinson, {Dan R.} and Kung, {Hsing Jien}",
year = "2004",
month = "10",
day = "15",
doi = "10.1158/0008-5472.CAN-04-0972",
language = "English",
volume = "64",
pages = "7311--7320",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "20",

}

TY - JOUR

T1 - Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells

AU - Wu, Yi Mi

AU - Robinson, Dan R.

AU - Kung, Hsing Jien

PY - 2004/10/15

Y1 - 2004/10/15

N2 - The AXL/UFO family of tyrosine kinases is characterized by a common N-CAM (neural adhesion molecule)-related extracellular domain and a common ligand, GAS6 (growth arrest-specific protein 6). Family members are prone to transcriptional regulation and carry out diverse functions including the regulation of cell adhesion, migration, phagocytosis, and survival. In this report, we describe a new role of MER/N-CAM-related kinase (NYK), a member of the AXL family of kinases, in the up-regulation of chemokines in prostate cancer cells. We show that NYK has elevated expression in a subset of tumor specimens and prostate cancer cell lines. Activation of NYK in the prostate cancer cell line DU145 does not cause a mitogenic effect; instead, it causes a differentiation phenotype. Microarray analysis revealed that NYK is a strong inducer of endocrine factors including interleukin (IL)-8 and several other angiogenic CXC chemokines as well as bone morphogenic factors. The dramatic increase of IL-8 expression is seen at both transcriptional and posttranscriptional levels. The downstream signals engaged by NYK were characterized, and those responsible for the up-regulation of IL-8 transcription were defined. In contrast to IL-1α, NYK-induced up-regulation of IL-8 in DU145 depends on the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase/Jun/Fos pathway, but not phosphoinositide 3′-kinase/ nuclear factor-κB. These data define a new function of the AXL family of kinases and suggest a potential role of NYK in prostate cancer progression.

AB - The AXL/UFO family of tyrosine kinases is characterized by a common N-CAM (neural adhesion molecule)-related extracellular domain and a common ligand, GAS6 (growth arrest-specific protein 6). Family members are prone to transcriptional regulation and carry out diverse functions including the regulation of cell adhesion, migration, phagocytosis, and survival. In this report, we describe a new role of MER/N-CAM-related kinase (NYK), a member of the AXL family of kinases, in the up-regulation of chemokines in prostate cancer cells. We show that NYK has elevated expression in a subset of tumor specimens and prostate cancer cell lines. Activation of NYK in the prostate cancer cell line DU145 does not cause a mitogenic effect; instead, it causes a differentiation phenotype. Microarray analysis revealed that NYK is a strong inducer of endocrine factors including interleukin (IL)-8 and several other angiogenic CXC chemokines as well as bone morphogenic factors. The dramatic increase of IL-8 expression is seen at both transcriptional and posttranscriptional levels. The downstream signals engaged by NYK were characterized, and those responsible for the up-regulation of IL-8 transcription were defined. In contrast to IL-1α, NYK-induced up-regulation of IL-8 in DU145 depends on the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase/Jun/Fos pathway, but not phosphoinositide 3′-kinase/ nuclear factor-κB. These data define a new function of the AXL family of kinases and suggest a potential role of NYK in prostate cancer progression.

UR - http://www.scopus.com/inward/record.url?scp=5644269051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5644269051&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-0972

DO - 10.1158/0008-5472.CAN-04-0972

M3 - Article

C2 - 15492251

AN - SCOPUS:5644269051

VL - 64

SP - 7311

EP - 7320

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 20

ER -